Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+22.9%
5Y CAGR+85.9%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+22.9%/yr
Annual compound
5Y CAGR
+85.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
22.2x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $113.52M | +7.3% |
| 2024 | $105.77M | +54.4% |
| 2023 | $68.51M | +12.0% |
| 2022 | $61.16M | +17.0% |
| 2021 | $52.29M | +924.1% |
| 2020 | $5.11M | - |